NL1004543C1 - Composed dietary supplement. - Google Patents
Composed dietary supplement. Download PDFInfo
- Publication number
- NL1004543C1 NL1004543C1 NL1004543A NL1004543A NL1004543C1 NL 1004543 C1 NL1004543 C1 NL 1004543C1 NL 1004543 A NL1004543 A NL 1004543A NL 1004543 A NL1004543 A NL 1004543A NL 1004543 C1 NL1004543 C1 NL 1004543C1
- Authority
- NL
- Netherlands
- Prior art keywords
- arginine
- dietary supplement
- carnitine
- pyridoxine
- ascorbic acid
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 9
- 229930064664 L-arginine Natural products 0.000 claims description 8
- 235000014852 L-arginine Nutrition 0.000 claims description 8
- 239000002211 L-ascorbic acid Substances 0.000 claims description 6
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 235000008160 pyridoxine Nutrition 0.000 claims description 5
- 239000011677 pyridoxine Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 3
- AEDORKVKMIVLBW-BLDDREHASA-N 3-oxo-3-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxy]oxan-2-yl]methoxy]propanoic acid Chemical compound OCC1=C(O)C(C)=NC=C1CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O1 AEDORKVKMIVLBW-BLDDREHASA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Description
Samengesteld voedingssupplementComposed dietary supplement
De onderhavige uitvinding heeft betrekking op een samengesteld voedingssupplement voor (top)sportlieden een breed publiek en ook voor toepassing in de klinische geneeskunde .The present invention relates to a composite nutritional supplement for (top) sportsmen to a wide audience and also for use in clinical medicine.
5 Voor het ondersteunen van duur- en krachttraining en voor langdurige prestaties is het bekend een voedingssupplement te gebruiken dat het metabolisme verbetert, de afbraak van vet bij de lichamelijke belasting versterkt en de eiwit-synthese in het spierweefsel gunstig beïnvloedt. Het basisbe-10 standdeel daarvoor zijn aminozuren, vooral arginine, die worden gecombineerd met speciale toevoegingen voor het verbeteren van het nuttige gebruik van de aminozuren. Verder worden ze gecombineerd met vitaminen of mineralen.For supporting endurance and strength training and for long-term performance, it is known to use a dietary supplement that improves metabolism, enhances the breakdown of fat during physical stress and favorably influences protein synthesis in muscle tissue. The basic constituent therefor are amino acids, especially arginine, which are combined with special additives to improve the useful use of the amino acids. Furthermore, they are combined with vitamins or minerals.
Het belangrijkste nadeel van dergelijke voedingssup-15 plementen is dat de samenstelling ervan is toegesneden op (top)sportlieden.The main drawback of such nutritional supplements is that their composition is tailored to (top) sportsmen.
De uitvinding beoogt een middel te verschaffen dat een gunstige invloed heeft voor een breed spectrum aan gebruikers, zonder dat zij bij gebruik nadelige nevenreacties 2 0 ervaren.The object of the invention is to provide an agent that has a beneficial effect on a wide spectrum of users, without experiencing adverse side reactions when used.
Het doel wordt volgens de onderhavige uitvinding bereikt met een L-carnitine- en L-arginine-bevattend samengesteld voedingssupplement, dat wordt gekenmerkt doordat L-carnitine en L-arginine zijn aangevuld met tenminste L-ascorbi-25 nezuur en pyridoxine in een gewichtsverhouding van: L-carnitine 100 tot 1200 mg, L-arginine 50 tot 1000 mg, L-ascorbinezuur 10 tot 1000 mg, en pyridoxine 1 tot 100 mg.The object is achieved according to the present invention with an L-carnitine and L-arginine-containing compound dietary supplement, characterized in that L-carnitine and L-arginine are supplemented with at least L-ascorbic acid and pyridoxine in a weight ratio of : L-carnitine 100 to 1200 mg, L-arginine 50 to 1000 mg, L-ascorbic acid 10 to 1000 mg, and pyridoxine 1 to 100 mg.
30 Een dergelijke samenstelling is geschikt voor (top)sportlieden, recreatiesporters, voor het verminderen van overgewicht, als voedingssupplement voor hartpatiënten, patiënten met urineproblemen en diabetici.Such a composition is suitable for (top) sportsmen, recreational athletes, for reducing obesity, as a dietary supplement for heart patients, patients with urinary problems and diabetics.
Voor het eenvoudig kunnen innemen ervan wordt het 35 voedingssupplement volgens de uitvinding bij voorkeur gekenmerkt doordat het voedingssupplement de vorm van een waterige 1004543 2 oplossing heeft, waarbij 5 ml van deze oplossing 600 mg L-carnitine, 200 mg L-arginine, 100 mg L-ascorbinezuur en 4 mg pyridoxine bevat.For ease of ingestion, the nutritional supplement according to the invention is preferably characterized in that the nutritional supplement is in the form of an aqueous 1004543 2 solution, wherein 5 ml of this solution are 600 mg L-carnitine, 200 mg L-arginine, 100 mg L -ascorbic acid and contains 4 mg pyridoxine.
5 Uitvoerinosvoorbeeld 600 mg L-carnitine, 200 mg L-arginine, 100 mg L-as-corbinezuur en 4 mg pyridoxine worden in water opgelost, en desgewenst worden smaak- en aromastoffen toegevoegd. Voor gebruik giet men de oplossing in een alcoholvrije drank naar 10 keuze, en is daarmee direct voor gebruik gereed.Output Example Example 600 mg of L-carnitine, 200 mg of L-arginine, 100 mg of L-as-corbic acid and 4 mg of pyridoxine are dissolved in water, and flavoring and flavoring agents are added if desired. Before use, the solution is poured into an alcohol-free drink of your choice, and is immediately ready for use.
Voor sportlieden is de geschikte dagelijkse dosis aan voedingssupplement 300 mg tot enkele grammen droge stof. Voor het terugbrengen van overgewicht door intensieve vetver-branding is de werkzame dosis van het voedingssupplement vol-15 gens de uitvinding gelegen tussen 300 mg tot 1000 mg droge stof, dagelijks gedurende ten minst 10 dagen.For sportsmen, the appropriate daily dose of dietary supplement is 300 mg to a few grams of dry matter. For obesity reduction by intensive fat burning, the effective dose of the dietary supplement according to the invention is between 300 mg to 1000 mg of dry matter, daily for at least 10 days.
Als voedingssupplement voor hartpatiënten, zieken met urineproblemen, respectievelijk bij hemodialyse zoals voor diabetici, is de geschikte dosis van het voedingssupple-20 ment volgens de uitvinding ca. 300 mg droge stof gedurende lange tijd. De verbetering van de situatie is aanzienlijk, vooral in die gevallen waarbij de gebruikers ook aan overgewicht lijden.As a dietary supplement for heart patients, patients with urinary problems, or for hemodialysis, such as for diabetics, the suitable dose of the nutritional supplement according to the invention is about 300 mg of dry matter for a long time. The situation has improved significantly, especially in those cases where users are also overweight.
10045431004543
Claims (2)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ19954660U CZ4392U1 (en) | 1995-11-16 | 1995-11-16 | Multicomponent nutrition supplement |
| CZ466095 | 1995-11-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL1004543C1 true NL1004543C1 (en) | 1997-05-21 |
Family
ID=5468291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1004543A NL1004543C1 (en) | 1995-11-16 | 1996-11-15 | Composed dietary supplement. |
Country Status (4)
| Country | Link |
|---|---|
| CZ (1) | CZ4392U1 (en) |
| DE (1) | DE29620015U1 (en) |
| NL (1) | NL1004543C1 (en) |
| PL (1) | PL183544B1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117872A (en) * | 1998-06-23 | 2000-09-12 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity |
| DE102004041270A1 (en) * | 2004-08-26 | 2006-03-02 | Merz Pharma Gmbh & Co. Kgaa | A capillary action system containing application differential differentiation compositions and their use |
-
1995
- 1995-11-16 CZ CZ19954660U patent/CZ4392U1/en not_active IP Right Cessation
-
1996
- 1996-11-15 PL PL96317013A patent/PL183544B1/en not_active IP Right Cessation
- 1996-11-15 NL NL1004543A patent/NL1004543C1/en not_active IP Right Cessation
- 1996-11-18 DE DE29620015U patent/DE29620015U1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PL317013A1 (en) | 1997-05-26 |
| CZ4392U1 (en) | 1996-02-07 |
| DE29620015U1 (en) | 1997-01-09 |
| PL183544B1 (en) | 2002-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100719715B1 (en) | Food supplement for increasing lean mass and strength | |
| US20080317886A1 (en) | Compositions for Preventing and Reducing Delayed Onset Muscle Soreness | |
| JP5714227B2 (en) | Anti-fatigue agent and oral composition containing andrographolide as active ingredient | |
| US6855727B2 (en) | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect | |
| RU2422049C2 (en) | Liquid compound based on guanidinoacetic acid component | |
| RU2156087C1 (en) | Biologically active addition | |
| CN101132786B (en) | Salts, addition compounds and complex compounds of guanidinoacetic acid | |
| WO2009099628A2 (en) | Compositions and methods for influencing recovery from strenuous physical activity | |
| CN105338824B (en) | Compositions and methods for improving athletic performance | |
| US20110123653A1 (en) | Compositions and methods for optimizing exercise recovery | |
| US20110135785A1 (en) | Methods for improving hepatic and immune function in an animal | |
| KR20150101458A (en) | Synergistic dietary supplement for enhancing physical performance | |
| WO2011096413A1 (en) | Agent for improving motility function | |
| ES2271042T3 (en) | FOOD SUPPLEMENT WITH A SLIMMING EFFECT. | |
| NL1004543C1 (en) | Composed dietary supplement. | |
| JP2000023635A (en) | Granule nutrient auxiliary food | |
| JP2002338473A (en) | Anti-fatigue composition | |
| JP2003535121A (en) | Kits and methods for optimizing the effectiveness of chondroprotective compositions | |
| CN106036387A (en) | Super chenopodium quinoa willd nutritional packet for promoting growth of children | |
| JP2000239179A (en) | Improvement of motility due to control of ammonia formation when taking exercise | |
| KR102582313B1 (en) | Composition for improving joint health by reducing body fat in companion dogs | |
| Bagavan Reddy et al. | Nutritional management of liver diseases in dogs and cats | |
| PT1093337E (en) | Food supplements comprising lipoic acid and creatine and methods for their use | |
| JP2001072590A (en) | Energy metabolism in motion by isoflavone derived from soybean | |
| JP2000302677A (en) | Medicine and food/feed composition having improving action on carnitine self production ability |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20010601 |